Cefuroxime Axetil

Author:

Marx Michael A.1,Fant William K.2

Affiliation:

1. University of Cincinnati, and a Staff Pharmacist, Good Samaritan Hospital, Cincinnati, OH

2. College of Pharmacy, University of Cincinnati, Cincinnati, OH

Abstract

Cefuroxime axetil is a orally active prodrug formulation of cefuroxime, which upon absorption undergoes immediate deesterification to free cefuroxime. Cefuroxime axetil offers an in vitro antibacterial spectrum against many gram-positive and some gram-negative organisms. Its beta-lactamase stability makes it useful in treating a variety of infections caused by beta-lactamase-producing strains of Haemophilus influenzae, Branhamella catarrhalis, and Staphylococcus aureus. Cefuroxime axetil has good activity against the Enterobacteriaceae and moderate activity against non-Bacteroides fragilis anaerobes. Clinical studies suggest it is at least as effective as ampicillin, amoxicillin, amoxicillin/clavulanic acid, penicillin V, or cefaclor in the treatment of uncomplicated urinary tract infections, acute otitis media, upper respiratory infections, skin and soft tissue infections, and uncomplicated gonorrhea.

Publisher

SAGE Publications

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Formulation and Optimization of Gastro retentive Glimepiride Floating Matrix Tablets;International Journal of pharma and Bio Sciences;2021-01-21

2. FORMULATION IN VITRO AND IN VIVO EVALUATION OF CEFUROXIME AXETIL FLOATING TABLETS USING NATURAL GUMS;International Journal of pharma and Bio Sciences;2019-02-13

3. Industrial Enzymatic Production of Cephalosporin-Based β-Lactams;Molecular Biotechnolgy of Fungal beta-Lactam Antibiotics and Related Peptide Synthetases;2004-10-04

4. Bioequivalence evaluation of two brands of cefuroxime 500 mg tablets (Cefuzime® and Zinnat®) in healthy human volunteers;Biopharmaceutics & Drug Disposition;2000-09

5. SHORT‐COURSE CEFUROXIME AXETIL THERAPY IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS;International Journal of Clinical Practice;1998-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3